Signia Pure C&G IX vs Yeasound RIC700

The Signia Pure C&G IX is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #22 among 39 prescription hearing aids tested. This device demonstrates notable strengths in speech clarity and feedback control. Speech in quiet scored 4.0/5, which is 0.57 points above the category average—a meaningful advantage for everyday conversations. Feedback handling achieved a perfect 5.0/5, sitting 0.28 points above the already-high category average of 4.72/5. Own-voice comfort also performed well at 3.2/5, exceeding the category average by 0.50 points. Speech in noise presents a more mixed picture. While the 2.2/5 score is technically above the category average by 0.10 points, it remains modest in absolute terms—something to consider if challenging listening environments are a priority. Music streaming scored a solid 3.0/5, sitting 0.24 points above average. The Pure C&G IX features rechargeable batteries and supports streaming to both iPhone and Android devices, including hands-free calling. At this premium price point, competitors like the Phonak Sphere Infinio (4.98/5) and Oticon Intent (4.83/5) achieve higher overall scores. This device may suit those who prioritize clear speech in quieter settings and excellent feedback stability, though buyers seeking stronger noise performance may want to compare alternatives.

The Yeasound RIC700 is a budget-priced OTC hearing aid that delivers A-grade performance in HearAdvisor's lab testing, placing it in the top 14% of the 65 OTC devices we've evaluated. At $399, it offers strong value for consumers seeking quality amplification without prescription-level costs. In our testing, the RIC700 excels at speech clarity in quiet environments, scoring 4.2/5—a strong result that sits 1.41 points above the OTC category average. Speech understanding in noisy settings scores 1.9/5, which is above the category average but remains low in absolute terms, a common limitation across OTC devices. Music streaming quality reaches 2.9/5, nearly a full point above the category average, though still mixed overall. Feedback handling is excellent at 4.6/5. The device does show some limitations. Own-voice comfort scores 2.0/5, falling 0.51 points below the category average—users may notice some occlusion effects when speaking. This behind-the-ear style features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The RIC700 competes well within its price bracket, though shoppers should note that the higher-ranked Yeasound RIC800 and Sony CRE-E10 are available at similar price points with stronger overall scores. For budget-conscious consumers prioritizing speech clarity in quieter listening situations, the RIC700 represents a solid option in the OTC market.